Osteointegration and Fusion After TLIF: Trabecular Titanium Cage with SVF-Hydrogel Compared with PEEK Cage.
Baidarbekov MU., Ipmagambetov ZN., DeLellis N., Bekarissov OS., Abdikalikov MS., Yestay DZ.
Prospective Study with a reported sample of 50 on Back & Spine, published in Orthop Rev (Pavia) (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Orthop Rev (Pavia) (2026)
- Country
- United States
- Reported sample size
- 50
- Source database
- PubMed
- PMID
- 41938028
- PMCID
- PMC13048841
- DOI
- 10.52965/001c.159611
Abstract (original English)
Background Degenerative lumbar spinal stenosis is a leading cause of disability, and lumbar interbody fusion (LIF) is a common surgical option. However, pseudarthrosis and suboptimal fusion remain important limitations. Porous titanium cages with biologically active hydrogels may enhance osteointegration compared with PEEK implants. Methods This single-centre prospective randomized trial included 50 patients with lumbar stenosis undergoing single-level TLIF. Patients were allocated 1:1 to Group I (trabecular Ti-6Al-4V cage with autologous bone and stromal-vascular fraction-based heparin-conjugated fibrin hydrogel) or Group II (PEEK cage with autologous bone only). Follow-up was 12 months. Primary endpoints were CT-based fusion at 12 months (Tan classification) and bone density within the cage region (Hounsfield units, HU). Secondary outcomes included pain (VAS), disability (ODI), implant subsidence/migration, operative parameters, and complications. Results Baseline demographic and clinical characteristics and intraoperative blood loss were comparable between groups. Mean HU values were significantly higher in Group I at 3-4, 6 and 12 months (428.0±68.6 vs 388.8±46.6, p=0.0228; 527.5±81.8 vs 466.4±52.7, p=0.0031; 594.8±78.7 vs 521.0±75.0, p=0.0014). Complete fusion (Tan grade 1) at 12 months was achieved in 68% of Group I versus 32% of Group II patients (p=0.0227). Group I also
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Stem cell therapy for degenerative disc disease: A systematic review of preclinical evidence, clinical translation, and future directions
Systematic Review on Back Pain, Disc Degeneration, published in N Am Spine Soc J (2026) — summary generated from the PubMed abstract.
- 2026
N Am Spine Soc J - Level AMeta-analysisEurope PMC
Association between platelet to lymphocyte ratio and the risk of vertebral fracture in patients with osteoporosis: a systematic review and meta-analysis
Meta-analysis on Back & Spine, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Endocrinol (Lausanne) - Level ASystematic ReviewEurope PMC
The Role of Exosome-miRNA as Biomarkers of Alzheimer's Disease: A Systematic Review of Case-Control and Longitudinal Studies
Systematic Review with a reported sample of 3046 on Neuroinflammation, published in Actas Esp Psiquiatr (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3046
Actas Esp Psiquiatr - Level AMeta-analysisEurope PMC
Platelet-Rich Plasma vs. Mesenchymal Stem Cells for Lumbar Disc Degeneration: A Systematic Review and Meta-Analysis
Meta-analysis on Disc Degeneration, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol